ADG106 drug page Clinical trials

Trials with ADG106

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
66Planned patients

Showing 1–1 of 1

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
Ongoing, not recruiting Phase 1 66 patients NCT05275777

This is an open label, lead in phase Ib dose confirmation study in patients with advanced solid tumors, followed by a phase II single arm study as neoadjuvant therapy in stage I-III HER2 negative breast cancer. Primary Objectives * To de…

Singapore May 2022 – Feb 2030 Interventional